期刊文献+

膀胱移行细胞癌中FHIT基因启动子甲基化及其蛋白的表达 被引量:3

Aberrant Methylation of FHIT Gene Promoter and its Protein Expression in Bladder Transitional Cell Carcinoma
原文传递
导出
摘要 目的:探讨膀胱移行细胞癌(BTCC)FHIT基因启动子甲基化状态及其与FHIT蛋白表达的关系。方法:采用甲基化特异性PCR(MS-PCR)方法及免疫组织化学S-P法检测62例BTCC组织和10例正常膀胱组织中FHIT基因启动子甲基化状态及FHIT蛋白表达。结果:BTCC组织、正常膀胱组织FHIT基因启动子甲基化频率分别为19.4%(12/62),0(0/10)。FHIT蛋白在正常膀胱组织、BTCC中阳性表达率分别为100.0%(10/10)和46.77%(29/62),肿瘤不同分级中随恶性程度的增高,表达减少,Ⅰ级与Ⅲ级比较,差异有统计学意义(P<0.05),不同临床分期中随分期的增高,表达减少,Tis~T_1与T_2~T_4比较,差异无统计学意义(P>0.05)。FHIT基因的启动子甲基化和蛋白阳性表达有相关(P<0.05)。结论:FHIT基因的启动子甲基化可能是基因失活重要机制之一,FHIT基因启动子甲基化及表达在BTCC的发生、发展中起重要作用。 Objective:To study the relationship between aberrant methylation of FHIT gene promoter and its protein expression in bladder transitional cell carcinoma (BTCC). Methods: Methylation-specific PCR (MS-PCR) and immunohistochemical S-P technique were used to detect the aberrant methylation of FHIT gene promoter and its protein expression in 62 cases of BTCC and 10 cases of normal urinary bladder tissues. Results:The frequencies of FHIT gene promoter in normal urinary bladder tissue and BTCC were 19.4 % (12/62) ,0 (0/10) respectively. The positive rate of FHIT expression in normal urinary bladder tissue and BTCC was 100.0% (t0/10) and 46. 77% (29/62) respectively. The expression of FHIT protein decreased with the high grade. Compared Ⅰ and Ⅲ grade, it had marked statistical significance (P〈0.05), the difference of positive rate between Tis T1 and T2-T4 cases showed a trend of decreasing, but there was no statistically significant difference (P〉0.05). There was correlation between methylation of FHIT gene promoter and expression of its protein (P〈0.05). Conclusions: Abet rant methylation of FHIT gene promoter might be one of important factors of inactivation of FHIT gene. Aberrant methylation of FHIT gene promoter and its protein expression play important role in the occurrence and develop- ment of the BTCC.
出处 《临床泌尿外科杂志》 北大核心 2009年第8期627-630,共4页 Journal of Clinical Urology
关键词 膀胱移行细胞癌 甲基化 抑癌基因 FHIT基因 bladder transitional cell carcinoma methylation anti-oncogene FHIT gene .
  • 相关文献

参考文献15

  • 1Ohta M, Inoue H, Cotticelli M G, et al. FHIT gene spanning the chromosome 3p14.2 fragile site and renal careinoma-assosiated t (3;8) breakpoint is abnormal in digestive tract eaneer[J]. Cell, 1996, 84(4):587-597.
  • 2Dhillon V S, Shahid M, Husain S A. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin[J]. Molecular Cancer, 2004,3:33.
  • 3Kanai Y, Ushijima S, Kondo Y, et al. DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers[J]. Int J Cancer, 2001,91(2):205-212.
  • 4Herman J G, Graff J R, Myohanen S, et al. Methylation specific PCR: a novel PCR assay for methylation status of CpG islands[J]. Proc Natl Acid Sci USA, 1996, 93(18) :9821-9826.
  • 5Hao X P, Willis J E, Pretlow T G, et al. Loss of fragile histidine triad expression in colorectal carcinomas and premalignent lesion[J]. Cancer Res, 2000, 60 (1) : 18-21.
  • 6赵坡,宋欣,宁元元,李向红.肝细胞癌脆性组氨酸三联体Fhit蛋白表达丢失研究[J].中华肝胆外科杂志,2004,10(1):52-54. 被引量:11
  • 7王守立,敬小梅,杨光华,步宏.FHIT基因与肿瘤[J].临床与实验病理学杂志,2004,20(2):233-235. 被引量:8
  • 8李长青,金春顺,张凌.喉鳞状细胞癌中PTEN和Caspase-3的表达及临床意义[J].临床耳鼻咽喉科杂志,2004,18(12):728-730. 被引量:4
  • 9殷德涛,董明敏.喉鳞状细胞癌中脆性组氨酸三联体基因启动子甲基化及其蛋白的表达[J].临床耳鼻咽喉科杂志,2005,19(6):253-255. 被引量:6
  • 10Zoehbauer Muller S, Fong K M, Maitra A, et al. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer [J]. Cancer Res, 2001, 61(9):3581-3585.

二级参考文献66

共引文献22

同被引文献34

  • 1Ke-JunNan,Zhi-PingRuan,ZhaoJing,Hai-XiaQin,Hong-YanWang,HuiGuo,RuiXu.Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis[J].World Journal of Gastroenterology,2005,11(2):228-231. 被引量:33
  • 2张利平,强荣,剡红民,李俊华,陶囡,刘慧,郑军.宫颈癌细胞FHIT基因启动子CpG岛甲基化状态分析[J].实用医技杂志,2007,14(10):1245-1246. 被引量:1
  • 3Taftachi R,Ayhan A,Ekici S,et al. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67[J]. BJU Int,2005,95 (14) : 650-654.
  • 4Stoeber K,Tlsty TD,Happerfield L,et al. DNA replication livensing and human cell proliferatior[J]. J Cell Science,2001,114(11):2027-2041.
  • 5Ozen H,Hall MC. Bladder cancer[J]. Curr Opin Oncol,2000,12(3): 255-259.
  • 6Hassen W,Droller MJ. Current concepts in assessment and treatment of bladder cancer[J]. Current Opinion in Urology,2000,10 (4): 291-299.
  • 7Maquoi E,Frankame F,Baramova E,et al. Membrane type-1 matrix of metalloproteinases assosiated degradation of tissue inhibitor of metalloproteinases 2 in human turn cell lines[J]. J Biol Chem,2000,97 (8) :3884-3889.
  • 8Garbea EA,Reed MW,Brown M,et al. Proteolysis in human breast and colorectal cancer[J]. Br J Cancer, 1999, 81 (2) : 287-293.
  • 9Schwingshack A,Duszyk M,Brown N,et al. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha[J]. J Allergy Clin Immunal, 1999, 104:983-989.
  • 10Michael M,Babic B,Khokha R,et al. Expressino and prognostic significance of metalloproteinase and their tissue inhibitors in patients with small-cell lung cancer[J]. J Clin Oncol, 1999,17(6): 1802-1808.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部